Fig. 1From: Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial resultsManual region of interest placement for radiomic analysis in a 56-year-old patient with a HER2-enriched invasive ductal carcinoma in the right breastBack to article page